ReachRxResearch
Home
Research
Sign Up
Amino acid mapping–guided scaffold selection and hit identification of histidine kinase inhibitors from a virtual library of over 12 million compounds
Back to Research Hub
  1. Home
  2. Research Hub
  3. Amino acid mapping–guided scaffold selec…

Amino acid mapping–guided scaffold selection and hit identification of histidine kinase inhibitors from a virtual library of over 12 million compounds

The Journal of Antibiotics·September 30Open Access
ImmunologyLimited evidenceAntimicrobial ResistanceBacterial InfectionIn Vitro Study With Computational ScreeningHistidine Kinase InhibitorVirtual Screening / Computational Drug DiscoveryFF-054FF-055FF-060Waldiomycin

Summary

View source

What was studied

Whether amino acid mapping (AAM)-based virtual screening of ~12 million commercially available compounds could identify novel non-naphthoquinone scaffolds that inhibit bacterial histidine kinases (HKs) by targeting the conserved H-box region, using waldiomycin's naphthoquinone moiety as the reference descriptor.

Key findings

Three 4H-pyrido[1,2-a]pyrimidin-4-one derivatives (FF-054, FF-055, FF-060) showed HK inhibitory activity with IC50 values of 4.39–259 µM against WalK, VicK, and EnvZ; FF-055 (IC50 6.92 µM) and FF-060 (IC50 4.39 µM) against VicK outperformed waldiomycin (IC50 25.8 µM), and NMR confirmed direct binding to the EnvZ DHp H-box domain.

Study limitations

No whole-cell antibacterial activity or cytotoxicity data are reported, so clinical relevance is unknown; IC50 values against WalK were weaker than waldiomycin (105–305 µM vs. 13.1 µM) for all new compounds; the AAM hit-selection threshold (0.75) was set empirically with an approximate 10% success rate, and binding affinities were not quantified (e.g., no Kd values).

Clinical implications

These compounds are early-stage research tools only—no clinical or antimicrobial application is yet warranted, but the AAM scaffold-hopping method represents a promising structure-independent strategy for finding new leads against bacterial two-component signaling systems, a target class with potential relevance to drug-resistant ESKAPE pathogens.

Caveats

  • All activity data are from cell-free biochemical assays only; no in vivo or whole-cell antimicrobial data are presented, limiting assessment of true antibacterial potential
  • IC50 values were determined by Western blot signal quantification of phosphohistidine, an indirect method with less precision than direct enzymatic or biophysical assays
  • The novel scaffold (pyrido[1,2-a]pyrimidin-4-one) was the ninth most frequent hit from AAM screening—not the top candidate—selected on novelty grounds, which may not reflect optimal potency

Related Questions

Explore related topics

What bacterial histidine kinase inhibitors have shown in vivo efficacy against ESKAPE pathogens?How do two-component signal transduction system inhibitors compare to traditional antibiotics for treating drug-resistant infections?What virtual screening methods are most effective for identifying novel antibiotic scaffolds without known protein structure?

Publication Details

Year
2026
Journal
The Journal of Antibiotics
Sample Size
n=15
Source
View article
Keep scrolling
More content below.
Up Next